Optimum Investment Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-200
| Closed | -$7.87K | – | 638 |
|
|
2024
Q4 | $7.87K | Hold |
200
| – | – | ﹤0.01% | 528 |
|
|
2024
Q3 | $9.4K | Hold |
200
| – | – | ﹤0.01% | 533 |
|
|
2024
Q2 | $10.8K | Hold |
200
| – | – | ﹤0.01% | 511 |
|
|
2024
Q1 | $13.6K | Hold |
200
| – | – | 0.01% | 494 |
|
|
2023
Q4 | $12.5K | Hold |
200
| – | – | 0.01% | 494 |
|
|
2023
Q3 | $9.08K | Buy |
200
+100
| +100% | +$4.54K | ﹤0.01% | 553 |
|
|
2023
Q2 | $5.61K | Hold |
100
| – | – | ﹤0.01% | 601 |
|
|
2023
Q1 | $4.52K | Hold |
100
| – | – | ﹤0.01% | 631 |
|
|
2022
Q4 | $4.07K | Hold |
100
| – | – | ﹤0.01% | 641 |
|
|
2022
Q3 | $7K | Hold |
100
| – | – | ﹤0.01% | 612 |
|
|
2022
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 646 |
|
|
2022
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 701 |
|
|
2021
Q4 | $8K | Sell |
100
-100
| -50% | -$8K | ﹤0.01% | 690 |
|
|
2021
Q3 | $22K | Sell |
200
-100
| -33% | -$11K | 0.01% | 584 |
|
|
2021
Q2 | $49K | Hold |
300
| – | – | 0.02% | 513 |
|
|
2021
Q1 | $37K | Hold |
300
| – | – | 0.01% | 559 |
|
|
2020
Q4 | $46K | Hold |
300
| – | – | 0.01% | 489 |
|
|
2020
Q3 | $25K | Hold |
300
| – | – | 0.01% | 563 |
|
|
2020
Q2 | $22K | Hold |
300
| – | – | 0.01% | 589 |
|
|
2020
Q1 | $13K | Hold |
300
| – | – | 0.01% | 642 |
|
|
2019
Q4 | $18K | Buy |
300
+245
| +445% | +$14.7K | 0.01% | 688 |
|
|
2019
Q3 | $2K | Buy |
+55
| New | +$2K | ﹤0.01% | 931 |
|